These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18455282)

  • 41. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 42. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants.
    Sarvas H; Kurikka S; Seppälä IJ; Mäkelä PH; Mäkelä O
    J Infect Dis; 1992 May; 165(5):977-9. PubMed ID: 1569355
    [No Abstract]   [Full Text] [Related]  

  • 43. Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier.
    Ijichi S; Matsuda T; Maruyama I; Izumihara T; Kojima K; Niimura T; Maruyama Y; Sonoda S; Yoshida A; Osame M
    Ann Rheum Dis; 1990 Sep; 49(9):718-21. PubMed ID: 2241290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody responses to tetanus toxoid in patients with primary biliary cirrhosis.
    Watmough D; French MA; Triger DR
    J Clin Pathol; 1987 Jun; 40(6):683-6. PubMed ID: 3497181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Salmonella infection with reference to serum immunoglobulin A, M and G levels in asymptomatic carriers].
    Drobnik S; Tkacz B; Zielonka Z
    Przegl Epidemiol; 1984; 38(1):57-60. PubMed ID: 6739837
    [No Abstract]   [Full Text] [Related]  

  • 46. Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia.
    Yarchoan R; Schneider HS; Wray BB; Nelson DL
    J Clin Invest; 1983 Jun; 71(6):1720-7. PubMed ID: 6863541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antibody response to tetanus and diphtheria toxoids in adult patients with solid neoplasms].
    Marconi P; Bistoni F; Mosci L; Tissi L; Vecchiarelli A; Di Leo S; Dominici C; Pitzurra M
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2264-70. PubMed ID: 754725
    [No Abstract]   [Full Text] [Related]  

  • 49. [Heterogeneity of diphtheria antibodies in rabbits immunized with diphtheria toxoid. II. Some properties of antibodies present in IgM and IgG immunoglobulins].
    Galazka A; Aleksandrowicz J; Mierzejewska H
    Med Dosw Mikrobiol; 1970; 22(2):145-52. PubMed ID: 5428964
    [No Abstract]   [Full Text] [Related]  

  • 50. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
    Freites A
    Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific antibody synthesis in vitro. II. Age-associated thymosin enhancement of antitetanus antibody synthesis.
    Ershler WB; Moore AL; Hacker MP; Ninomiya J; Naylor P; Goldstein AL
    Immunopharmacology; 1984 Oct; 8(2):69-77. PubMed ID: 6511366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of diphtheria antitoxin antibody in Epstein-Barr virus-induced lymphoblastoid cell lines.
    Tsuchiya S; Yokoyama S; Yoshie O; Ono Y
    J Immunol; 1980 Apr; 124(4):1970-6. PubMed ID: 6245131
    [No Abstract]   [Full Text] [Related]  

  • 54. Asymptomatic malaria parasitaemia and the antibody response to tetanus toxoid vaccination.
    Corrigall RJ
    Trans R Soc Trop Med Hyg; 1988; 82(4):540-1. PubMed ID: 3256105
    [No Abstract]   [Full Text] [Related]  

  • 55. Inability of patients with common variable hypogammaglobulinemia to generate lymphjoblastoid B cells following booster immunization.
    Stevens RH; Tamaroff M; Saxon A
    Clin Immunol Immunopathol; 1980 Jul; 16(3):336-43. PubMed ID: 6967385
    [No Abstract]   [Full Text] [Related]  

  • 56. [Characteristics of the serologic antibacterial response of patients with diphtheria and of bacterial carriers].
    Shmeleva EA; Kondrashina NN; Beresten' SF; Markina SS; Arzhevitina KV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):100-3. PubMed ID: 3149838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential synthesis of IgM and IgA anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans.
    Stevens RH; Saxon A
    Cell Immunol; 1979 Jun; 45(1):142-50. PubMed ID: 455480
    [No Abstract]   [Full Text] [Related]  

  • 58. [Mechanism of formation in diphtheria of antimicrobiol antibodies of different physiocochemical nature].
    Mazurova IK; Malasheva OK; Bochkova VA; Filippova LM
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jul; (7):108-12. PubMed ID: 4454857
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-tetanus toxoid antibodies in intravenous gamma globulin: an alternative to tetanus immune globulin.
    Lee DC; Lederman HM
    J Infect Dis; 1992 Sep; 166(3):642-5. PubMed ID: 1500750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY; Lim AH; Park JY; Han SH; Cho NS
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.